Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Andreoni

Showing results (131-140 of 306) with videos related to

Pageof 31
Sort By:
Methods (San Diego, Calif.)|May 17, 2021
Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartmentLorenzo Piermatteo, Rossana Scutari, Riccardo Chirichiello, et al.
American Journal of Hematology|April 29, 2010
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositisLoredana Sarmati, Angela Beltrame, Luca Dori, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 6, 2020
Disruption of brain network organization in patients with human immunodeficiency virus (HIV) infectionSilvia Minosse, Eliseo Picchi, Francesca Di Giuliano, et al.
Current Medical Research and Opinion|February 7, 2023
Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19Marco Infante, Massimo Pieri, Santina Lupisella, et al.
Journal of Medical Virology|May 23, 2007
Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimensLoredana Sarmati, Saverio Giuseppe Parisi, Emanuele Nicastri, et al.
Scientific Reports|August 18, 2019
HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapyVincenzo Malagnino, Carlotta Cerva, Gaetano Maffongelli, et al.
International Immunopharmacology|August 2, 2021
Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infectionFlaminia Tomassetti, Marzia Nuccetelli, Serena Sarubbi, et al.
Microorganisms|August 7, 2021
Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of ArtMaria Letizia Minardi, Ilenia Fato, Francesco Di Gennaro, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
Resistance to Ceftazidime/Avibactam in <i>Klebsiella pneumoniae</i> KPC-Producing Isolates: A Real-Life Observational StudyLaura Campogiani, Pietro Vitale, Alessandra Lodi, et al.
Plos One|July 23, 2013
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophagesMatteo Surdo, Emanuela Balestra, Patrizia Saccomandi, et al.
Pageof 31

Showing results (131-140 of 306) with videos related to

Sort By:
Pageof 31
Methods (San Diego, Calif.)|May 17, 2021
Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartmentLorenzo Piermatteo, Rossana Scutari, Riccardo Chirichiello, et al.
American Journal of Hematology|April 29, 2010
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositisLoredana Sarmati, Angela Beltrame, Luca Dori, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 6, 2020
Disruption of brain network organization in patients with human immunodeficiency virus (HIV) infectionSilvia Minosse, Eliseo Picchi, Francesca Di Giuliano, et al.
Current Medical Research and Opinion|February 7, 2023
Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19Marco Infante, Massimo Pieri, Santina Lupisella, et al.
Journal of Medical Virology|May 23, 2007
Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimensLoredana Sarmati, Saverio Giuseppe Parisi, Emanuele Nicastri, et al.
Scientific Reports|August 18, 2019
HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapyVincenzo Malagnino, Carlotta Cerva, Gaetano Maffongelli, et al.
International Immunopharmacology|August 2, 2021
Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infectionFlaminia Tomassetti, Marzia Nuccetelli, Serena Sarubbi, et al.
Microorganisms|August 7, 2021
Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of ArtMaria Letizia Minardi, Ilenia Fato, Francesco Di Gennaro, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
Resistance to Ceftazidime/Avibactam in <i>Klebsiella pneumoniae</i> KPC-Producing Isolates: A Real-Life Observational StudyLaura Campogiani, Pietro Vitale, Alessandra Lodi, et al.
Plos One|July 23, 2013
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophagesMatteo Surdo, Emanuela Balestra, Patrizia Saccomandi, et al.
Pageof 31